JAK2 and gastric cancer: One study shows that JAK2 or STAT3 inhibitor reduces 5-FU resistance and autophagy through ATF6-mediated ER stress in gastric cancer cells, which also enhances the sensitivity of gastric cancer cells for 5-FU [14].